COVID-19 Vaccination and Timing of Bariatric Surgery: Considerations and Concerns for Patients with Severe Obesity

Pazouki, Abdolreza; Shahabi, Shahab; Sheikhbahaei, Erfan; Mokhber, Sommayeh; Jazi, Amir Hossein Davarpanah; Kermansaravi, Mohammad

doi:10.1007/s11695-021-05734-x

Cited by 2 publications

(3 citation statements)

References 20 publications

(24 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As physicians, we strongly recommend that patients not delay their COVID-19 vaccines, especially considering the risks of Sars-Cov-2 infections for individuals with severe obesity, 20 and the lack of evidence on the adverse impact of COVID-19 in bariatric patients. 21,22 Despite the small study sample, to the best of our knowledge, this is the first report on timing of COVID-19 vaccination among patients undergoing MBS. This is of potentially great clinical value for surgeons.…”

Section: Discussionmentioning

confidence: 92%

“…These recommendations should be considered with caution in light of the aforementioned reports correlating COVID-19 vaccines to VTE. As physicians, we strongly recommend that patients not delay their COVID-19 vaccines, especially considering the risks of Sars-Cov-2 infections for individuals with severe obesity,20 and the lack of evidence on the adverse impact of COVID-19 in bariatric patients 21,22…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Timing of Bariatric Surgery and COVID-19 Vaccination: Experience From a High-volume Single Center

Vitiello

Berardi

Velotti

et al. 2023

Surgical Laparoscopy, Endoscopy &Amp; Percutaneous Techniques

View full text Add to dashboard Cite

Background: During the last year, there was a large COVID-19 vaccination campaign in Italy. Concurrently, metabolic bariatric surgery (MBS) restarted after a long period of discontinuity. No data are currently available on the best timing of COVID-19 vaccination for MBS candidates. The aim of this study was to report MBS outcomes in relation to the timing of COVID-19 vaccine administration.Materials and Methods: A prospectively maintained database was utilized to locate patients undergoing MBS between January 1 and December 31, 2021. Patients were divided into 2 groups: patients receiving a vaccine dose within 30 days before or after surgery (Group ± 30); and patients with a longer time interval of vaccine dose before or after surgery (Group > ± 30). Postoperative outcomes were recorded and compared.Results: A total of 108 patients were included: 33 (30.6%) of whom were in Group ± 30 and 74(69.4%) in Group > 30. Baseline characteristics were comparable between the 2 groups. Findings revealed that postoperative outcomes (ie, 30-d complications and length of stay postoperatively) were comparable between groups. Two patients in the ± 30 group had mesenteric vein thrombosis after sleeve gastrectomy (SG); however, the rate of thrombosis events was comparable between groups (P = 0.09). Thrombosis between SG patients were not significantly different between the 2 groups.Conclusions: COVID-19 vaccination within 30 days of MBS does not impact complication rates and length of stay. COVID-19 vaccination may have a negative impact on venous thrombosis after SG, but this study is underpowered to draw this conclusion. Larger studies should be conducted to replicate current study findings.

show abstract

Section: Discussionmentioning

confidence: 92%

Section: Discussionmentioning

confidence: 99%

Timing of Bariatric Surgery and COVID-19 Vaccination: Experience From a High-volume Single Center

Vitiello

Berardi

Velotti

et al. 2023

Surgical Laparoscopy, Endoscopy &Amp; Percutaneous Techniques

View full text Add to dashboard Cite

show abstract

“…

We would like to share ideas on "COVID-19 Vaccination and Timing of Bariatric Surgery: Considerations and Concerns for Patients with Severe Obesity [1]." Pazouki et al noted that "we encourage operating on fully vaccinated patients…… the second shot of the vaccine and the surgery, with more preference for the latter due to its lower likelihood of infection after surgery" [1]. We agree that it is necessary to prevent COVID-19 for the patient.

…”

mentioning

confidence: 99%